Blood: Doubling Down on Femcare Innovation with DSG Consumer Partners in Series B
Deal News | Feb 10, 2025 | DSG Consumer Partners
DSG Consumer Partners has announced a continued and expanded partnership with Blood, a menstrual care company focusing on providing innovative femcare solutions across Southeast Asia. The private equity firm's investment is leading Blood's Series B round, aimed at propelling the company's growth in the femcare market. Blood stands out with its rash-free, ultra-thin menstrual products and strategic omnichannel approach. Through partnerships with major retailers like Watsons, Guardian, and TikTok leverage, Blood has significantly increased its market presence in Singapore and Malaysia, achieving remarkable sales velocity. The brand's new campaign, 'Periods Aren't Cute', is a notable effort to normalize menstruation, engaging communities with impactful marketing. Blood also plans to expand its efforts into Indonesia while maintaining its consumer-centric philosophy to meet the demands of a growing market and create a lasting positive impact on women's health and comfort.
Sectors
- Private Equity Investment
- Femcare/Consumer Goods
- Retail and E-commerce
Geography
- Southeast Asia – Blood operates predominantly in Southeast Asian markets, including Singapore, Malaysia, and soon aims to expand into Indonesia.
- Singapore – One of the key markets for Blood where they have expanded their retail presence significantly.
- Malaysia – Another major market where Blood has established a strong presence in leading retail chains.
Industry
- Private Equity Investment – DSG Consumer Partners is a private equity firm investing in growth-stage companies like Blood.
- Femcare/Consumer Goods – Blood is a company focused on producing female menstrual care products, addressing needs within the femcare market.
- Retail and E-commerce – Blood utilizes omnichannel strategies, including partnerships with physical retailers and significant online sales strategies on platforms like TikTok and Shopee.
Financials
- Series B round – DSG Consumer Partners leading the Series B investment in Blood, indicating financial backing aimed at enhancing the company's market presence and expansion.
- 70% topline growth – Blood reported a significant revenue growth of over 70% in 2024, showcasing the company's successful performance.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Blood | Target Company | Companies | A company specializing in menstrual care products aimed at addressing women's comfort and health in Southeast Asia. |
| DSG Consumer Partners | Investor | Companies | A private equity firm leading the Series B Round to support Blood's growth in the femcare market. |
| Peck Ying | Co-Founder | People | Co-founder of Blood who plays a critical role in the company's strategic direction. |
| Caleb Leow | Co-Founder | People | Co-founder of Blood working alongside Peck Ying to drive their vision and company growth. |